Yuehong Cui

2.3k total citations · 1 hit paper
79 papers, 1.4k citations indexed

About

Yuehong Cui is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Surgery. According to data from OpenAlex, Yuehong Cui has authored 79 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 47 papers in Pulmonary and Respiratory Medicine, 37 papers in Oncology and 21 papers in Surgery. Recurrent topics in Yuehong Cui's work include Gastric Cancer Management and Outcomes (33 papers), Colorectal Cancer Treatments and Studies (16 papers) and Cholangiocarcinoma and Gallbladder Cancer Studies (14 papers). Yuehong Cui is often cited by papers focused on Gastric Cancer Management and Outcomes (33 papers), Colorectal Cancer Treatments and Studies (16 papers) and Cholangiocarcinoma and Gallbladder Cancer Studies (14 papers). Yuehong Cui collaborates with scholars based in China, United States and United Kingdom. Yuehong Cui's co-authors include Tianshu Liu, Yiyi Yu, Ai‐Wu Ke, Shan Yu, Jia‐Cheng Lu, Xiaoyong Huang, Pengfei Zhang, Yi-Min Zheng, Yi Li and Siwei Wang and has published in prestigious journals such as Nature Communications, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Yuehong Cui

77 papers receiving 1.4k citations

Hit Papers

Current applications and future perspective of CRISPR/Cas... 2022 2026 2023 2024 2022 50 100 150 200 250
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Current applications and future perspective of CRISPR/Cas9 gene editing in cancer
    2022 292 citations Siwei Wang, Chao Gao et al. Molecular Cancer profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yuehong Cui China 21 681 530 370 317 228 79 1.4k
Brian P. Adley United States 22 724 1.1× 347 0.7× 405 1.1× 313 1.0× 242 1.1× 30 1.5k
Katsumi Koshikawa Japan 16 921 1.4× 675 1.3× 316 0.9× 289 0.9× 237 1.0× 31 1.5k
Sarah Derks Netherlands 19 651 1.0× 766 1.4× 517 1.4× 298 0.9× 367 1.6× 54 1.6k
Jari Sundström Finland 22 484 0.7× 520 1.0× 295 0.8× 332 1.0× 151 0.7× 49 1.2k
Tingguo Zhang China 26 626 0.9× 451 0.9× 361 1.0× 276 0.9× 404 1.8× 67 1.5k
Zongwu Lin China 24 602 0.9× 341 0.6× 532 1.4× 297 0.9× 186 0.8× 61 1.3k
Dahmane Oukrif United Kingdom 18 671 1.0× 780 1.5× 364 1.0× 434 1.4× 455 2.0× 36 1.8k
Hongyong He China 22 546 0.8× 784 1.5× 490 1.3× 262 0.8× 255 1.1× 63 1.7k
Johannes Betge Germany 16 496 0.7× 706 1.3× 238 0.6× 210 0.7× 234 1.0× 43 1.2k
Nam‐Yun Cho South Korea 23 752 1.1× 661 1.2× 220 0.6× 258 0.8× 267 1.2× 43 1.4k

Countries citing papers authored by Yuehong Cui

Since Specialization
Citations

This map shows the geographic impact of Yuehong Cui's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yuehong Cui with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yuehong Cui more than expected).

Fields of papers citing papers by Yuehong Cui

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yuehong Cui. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yuehong Cui. The network helps show where Yuehong Cui may publish in the future.

Co-authorship network of co-authors of Yuehong Cui

This figure shows the co-authorship network connecting the top 25 collaborators of Yuehong Cui. A scholar is included among the top collaborators of Yuehong Cui based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yuehong Cui. Yuehong Cui is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Yang, Mengyuan, Ding Zhang, Daici Chen, et al.. (2025). Uncovering the genetic variation spectrum of colorectal polyposis from a multicentre cohort in China. npj Precision Oncology. 9(1). 75–75. 1 indexed citations
2.
Min, Lingqiang, Bo Zhou, Peng Zhou, et al.. (2024). Transarterial Infusion Chemotherapy and Embolization for Patients With Unresectable Advanced Cancer of Stomach or Gastroesophageal Junction: A Retrospective Study. Cancer Medicine. 13(21). e70396–e70396. 1 indexed citations
3.
Cui, Yuehong, et al.. (2024). Genetic association between COVID-19 and male infertility: a two-sample Mendelian randomization analysis. SHILAP Revista de lepidopterología. 20(1). 62–62. 1 indexed citations
4.
Zhang, Shilong, Yì Wáng, Li Liang, et al.. (2024). Nivolumab plus anlotinib hydrochloride in advanced gastric adenocarcinoma and esophageal squamous cell carcinoma: the phase II OASIS trial. Nature Communications. 15(1). 8876–8876. 7 indexed citations
5.
Xu, Xiaojing, Luoyan Ai, Li Liang, et al.. (2024). Tislelizumab plus cetuximab and irinotecan in refractory microsatellite stable and RAS wild-type metastatic colorectal cancer: a single-arm phase 2 study. Nature Communications. 15(1). 7255–7255. 16 indexed citations
6.
Heinrich, Michael C., Robin L. Jones, Suzanne George, et al.. (2023). Clinical Benefit of Avapritinib in KIT- Mutant Gastrointestinal Stromal Tumors: A Post Hoc Analysis of the Phase I NAVIGATOR and Phase I/II CS3007–001 Studies. Clinical Cancer Research. 30(4). 719–728. 4 indexed citations
7.
Hong, Weifeng, Dexiang Zhu, Yanjie Chen, et al.. (2023). Coiled-coil domain-containing 154 promotes colorectal cancer proliferation and metastasis via interacting with minichromosome maintenance complex component 2. Cancer Letters. 578. 216460–216460. 3 indexed citations
8.
Heinrich, Michael C., Jian Li, Robin L. Jones, et al.. (2023). Clinical efficacy of avapritinib in gastrointestinal stromal tumors (GIST) with different KIT genotypes: Post hoc analysis of the phase 1 NAVIGATOR and phase 1/2 CS3007-101 trials.. Journal of Clinical Oncology. 41(16_suppl). 11523–11523. 1 indexed citations
9.
Lv, Minzhi, Wei Li, Yan Wang, et al.. (2023). Efficacy of Pyrotinib With/Without Trastuzumab in Treatment-Refractory, HER2-Positive Metastatic Colorectal Cancer: Result From a Prospective Observational Study. Clinical Colorectal Cancer. 23(1). 58–66. 5 indexed citations
10.
11.
12.
13.
Wang, Siwei, Chao Gao, Yi-Min Zheng, et al.. (2022). Current applications and future perspective of CRISPR/Cas9 gene editing in cancer. Molecular Cancer. 21(1). 57–57. 292 indexed citations breakdown →
14.
Liang, Li, Xun Sun, Ke Peng, et al.. (2021). Identification of key genes involved in tumor immune cell infiltration and cetuximab resistance in colorectal cancer. Cancer Cell International. 21(1). 135–135. 8 indexed citations
15.
16.
Yu, Shan, Qian Li, Yiyi Yu, et al.. (2020). Activated HIF1α of tumor cells promotes chemoresistance development via recruiting GDF15-producing tumor-associated macrophages in gastric cancer. Cancer Immunology Immunotherapy. 69(10). 1973–1987. 38 indexed citations
17.
Li, Wei, Huiqin Jiang, Yiyi Yu, et al.. (2019). <p>Outcomes of gastrectomy following upfront chemotherapy in advanced gastric cancer patients with a single noncurable factor: a cohort study</p>. Cancer Management and Research. Volume 11. 2007–2013. 5 indexed citations
18.
19.
Jiang, Huiqin, Quan‐Lin Li, Shan Yu, et al.. (2016). Impact of HER2 expression on outcome in gastric cancer patients with liver metastasis. Clinical & Translational Oncology. 19(2). 197–203. 9 indexed citations
20.
Li, Wěi, Tianshu Liu, Yihong Sun, et al.. (2011). [Adjuvant chemotherapy for gastric cancer: more drugs do not mean better efficacy].. PubMed. 14(6). 432–5. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Brian P. Adley Breakdown of academic impact, for papers by Katsumi Koshikawa Breakdown of academic impact, for papers by Sarah Derks Breakdown of academic impact, for papers by Jari Sundström Breakdown of academic impact, for papers by Tingguo Zhang Breakdown of academic impact, for papers by Zongwu Lin Breakdown of academic impact, for papers by Dahmane Oukrif Breakdown of academic impact, for papers by Hongyong He Breakdown of academic impact, for papers by Johannes Betge Breakdown of academic impact, for papers by Nam‐Yun Cho
Rankless by CCL
2026